| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |